226 related articles for article (PubMed ID: 30465211)
1. Establishment of Slice Cultures as a Tool to Study the Cancer Immune Microenvironment.
Jiang X; Seo YD; Sullivan KM; Pillarisetty VG
Methods Mol Biol; 2019; 1884():283-295. PubMed ID: 30465211
[TBL] [Abstract][Full Text] [Related]
2. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
[TBL] [Abstract][Full Text] [Related]
3. Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment.
Jiang X; Seo YD; Chang JH; Coveler A; Nigjeh EN; Pan S; Jalikis F; Yeung RS; Crispe IN; Pillarisetty VG
Oncoimmunology; 2017; 6(7):e1333210. PubMed ID: 28811976
[TBL] [Abstract][Full Text] [Related]
4. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal.
Mundry CS; Eberle KC; Singh PK; Hollingsworth MA; Mehla K
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188387. PubMed ID: 32579889
[TBL] [Abstract][Full Text] [Related]
5. Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.
Blair AB; Zheng L
Chin Clin Oncol; 2017 Jun; 6(3):31. PubMed ID: 28705008
[TBL] [Abstract][Full Text] [Related]
6. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
[TBL] [Abstract][Full Text] [Related]
7. A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies.
Chadwick EJ; Yang DP; Filbin MG; Mazzola E; Sun Y; Behar O; Pazyra-Murphy MF; Goumnerova L; Ligon KL; Stiles CD; Segal RA
J Vis Exp; 2015 Nov; (105):e53304. PubMed ID: 26575352
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma.
Misra S; Moro CF; Del Chiaro M; Pouso S; Sebestyén A; Löhr M; Björnstedt M; Verbeke CS
Sci Rep; 2019 Feb; 9(1):2133. PubMed ID: 30765891
[TBL] [Abstract][Full Text] [Related]
9. An Immunological Glance on Pancreatic Ductal Adenocarcinoma.
Melzer MK; Arnold F; Stifter K; Zengerling F; Azoitei N; Seufferlein T; Bolenz C; Kleger A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397303
[TBL] [Abstract][Full Text] [Related]
10. Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism.
Jiang H; Courau T; Borison J; Ritchie AJ; Mayer AT; Krummel MF; Collisson EA
Gastroenterology; 2022 Feb; 162(2):590-603.e14. PubMed ID: 34627860
[TBL] [Abstract][Full Text] [Related]
11. Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.
Zheng L; Xue J; Jaffee EM; Habtezion A
Gastroenterology; 2013 Jun; 144(6):1230-40. PubMed ID: 23622132
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic ductal adenocarcinoma: a review of immunologic aspects.
Wachsmann MB; Pop LM; Vitetta ES
J Investig Med; 2012 Apr; 60(4):643-63. PubMed ID: 22406516
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry.
An X; Ouyang X; Zhang H; Li T; Huang YY; Li Z; Zhou D; Li QX
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30371656
[TBL] [Abstract][Full Text] [Related]
14. Protocol to culture and image pancreatic ductal adenocarcinoma tumor slices to study T cell migration.
Rodríguez-Merced NJ; Callaway MK; Provenzano PP
STAR Protoc; 2023 Mar; 4(1):102135. PubMed ID: 36861840
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
Sahin IH; Askan G; Hu ZI; O'Reilly EM
Ann Oncol; 2017 Dec; 28(12):2950-2961. PubMed ID: 28945842
[TBL] [Abstract][Full Text] [Related]
16. Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma.
Pandey V; Storz P
Expert Rev Anticancer Ther; 2019 Jun; 19(6):473-482. PubMed ID: 31148495
[No Abstract] [Full Text] [Related]
17. Mobilization of CD8
Seo YD; Jiang X; Sullivan KM; Jalikis FG; Smythe KS; Abbasi A; Vignali M; Park JO; Daniel SK; Pollack SM; Kim TS; Yeung R; Crispe IN; Pierce RH; Robins H; Pillarisetty VG
Clin Cancer Res; 2019 Jul; 25(13):3934-3945. PubMed ID: 30940657
[TBL] [Abstract][Full Text] [Related]
18. Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy.
Torphy RJ; Schulick RD; Zhu Y
Mol Carcinog; 2020 Jul; 59(7):775-782. PubMed ID: 32166821
[TBL] [Abstract][Full Text] [Related]
19. Promising Therapeutic Approach in Pancreatic Cancer: Metabolism-Related Genes.
Choe S; Kwak W; Kim E; Shin S; Shin M; Koh HJ; Yoon H
Front Biosci (Landmark Ed); 2024 Apr; 29(4):137. PubMed ID: 38682209
[TBL] [Abstract][Full Text] [Related]
20. Challenges and Opportunities for Pancreatic Cancer Immunotherapy.
Bear AS; Vonderheide RH; O'Hara MH
Cancer Cell; 2020 Dec; 38(6):788-802. PubMed ID: 32946773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
